<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00836524</url>
  </required_header>
  <id_info>
    <org_study_id>SJ-55</org_study_id>
    <nct_id>NCT00836524</nct_id>
  </id_info>
  <brief_title>Is Serum YKL-40 Capable of Predicting Intrauterine Growth Restriction (IUGR) and Preeclampsia?</brief_title>
  <official_title>&quot;Kan IUGR og præeclampsi Forudsiges ud Fra YKL-40 målt i Serum?&quot; &quot;Metoder Til at Vurdere om Den Gravide Har Risiko for at Udvikle Svangerskabsforgiftning og/Eller væksthæmning Hos Fosteret&quot;.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zealand University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Region Zealand</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Copenhagen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Zealand University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objective: To investigate the role of maternal serum YKL-40 and uterine artery doppler, at
      gestational age 12, 20, 25 and 32 weeks, and the relation to preeclampsia and intrauterine
      growth restriction. The serum marker YKL-40 is related to conditions involving inflammation,
      infection, tissue remodeling, fibrosis and cancer. IUGR and preeclampsia are known to be
      related to inflammation and tissue remodeling.

      Methods: women attending screening for downs syndrome is scanned with uterine artery doppler
      and delivered blood samples at GA 12, 20, 25 and 32 respectively. When pregnancy outcome is
      registered by medical records blood samples are retrieved and analyzed for serum YKL-40.
      Serum YKL-40 are correlated to the presence of bilateral notching, preeclampsia and different
      degrees of intrauterine growth restriction.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>January 2009</start_date>
  <completion_date type="Anticipated">September 2012</completion_date>
  <primary_completion_date type="Anticipated">November 2011</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">2000</enrollment>
  <condition>Intrauterine Growth Restriction</condition>
  <condition>Preeclampsia</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>Pregnant women are included when they attend nuchal transcluency examination and will during their pregnancy be examined 4 times with ultrasound</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>ultrasound</intervention_name>
    <description>4 ultrasound examinations during pregnancy and every time a blood sample is colletted. blood sample from the mother and the umbilical cord is collected as well</description>
    <arm_group_label>1</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Bloodsamples will be collected as well as placenta tissue for histology.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Pregnant women attending nuchal transcluency examination at Gynækologisk-Obstetrisk dept.
        Roskilde University Hospital
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Pregnant danish speeking women

        Exclusion Criteria:

          -  Conditions/diseases involving chronical inflammation, or immunological activity
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Estrid Høgdall, PhD leader</last_name>
    <role>Study Director</role>
    <affiliation>Dept of Pathology Herlev Hospital, Denmark</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Julia S. Johansen, Dr med prof</last_name>
    <role>Study Director</role>
    <affiliation>Dept. of oncology and medicine, Herlev Hospital, Denmark</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Gynækologisk-Obstetrisk Afdeling, Sygehus Nord</name>
      <address>
        <city>Roskilde</city>
        <state>Region Sjælland</state>
        <zip>4000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>October 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2009</study_first_submitted>
  <study_first_submitted_qc>February 3, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 4, 2009</study_first_posted>
  <last_update_submitted>October 27, 2011</last_update_submitted>
  <last_update_submitted_qc>October 27, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 28, 2011</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zealand University Hospital</investigator_affiliation>
    <investigator_full_name>Dorte Nymark Brask</investigator_full_name>
    <investigator_title>MD, phd student</investigator_title>
  </responsible_party>
  <keyword>IUGR</keyword>
  <keyword>Preeclampsia</keyword>
  <keyword>ultrasound</keyword>
  <keyword>YKL-40</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pre-Eclampsia</mesh_term>
    <mesh_term>Fetal Growth Retardation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>CHI3L1 protein, human</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

